Clinical Trial Readiness is our primary funding focus. While multiple precision treatment strategies are in development for 5p- syndrome, none are yet available for patients. Our mission is to accelerate the availability of safe and effective treatments that meaningfully modify 5p- syndrome to reduce suffering for patients and families.

We prioritize research in these critical areas:

• Biology - fundamental research into 5p- syndrome mechanisms

• Translational science - bridging laboratory discoveries to clinical applications

• Biomarkers and endpoints - developing measurable outcomes for clinical trials

• Patient network development - establishing multidisciplinary clinic networks

Seed Grants

Up to $25,000 | One year duration

Perfect for small proof-of-concept research projects or procurement of research assets to initiate 5p- syndrome research.

Trainee Grants

Up to $65,000 | One year duration

Typically fund salary and research costs for postdoctoral fellows studying 5p- syndrome. Renewable for a second year at CDCRF's discretion. Status reports required every six months.

Investigator Awards

Up to $130,000 | Up to two years

Support comprehensive studies including synaptic function research, protein-protein interactions, drug action in 5p- syndrome models, and translational precision medicine research. Status reports required every six months.

Clinical Network Support

Variable funding | Variable duration

Supports establishment or continuation of multidisciplinary clinics for patient care and Natural History Study data collection.

Presentation Requirement: All grant recipients present their work at the Cri du Chat Research Foundation's Annual Science Conference.

Indirect Costs Policy: CDCRF has a board-directed policy that does not allow payment of indirect costs to nonprofit institutions. Review our Indirect Costs Policy →

Reporting: Trainee grants and Investigator awards require status reports every six months.